B-pVAC-SARS-CoV-2: Study to Prevent COVID-19 Infection in Adults With Bcell/ Antibody Deficiency

Clinical trial NCT04954469 · COMPLETED

Trial details

NCT number: NCT04954469
Sponsor: University Hospital Tuebingen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immune Deficiency Disease

Start date: 2021-06-30
Primary completion: 2022-08-18
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.